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Objective To compare the chromosomal types ofMycobacterium avium strains infectingHIV-negative and
AIDS patients in Greece.
Methods In total, 41Mycobacterium avium isolates, 23 fromAIDS and18 fromHIV-negative patients, were
compared by pulsed-¢eld gel electrophoresis of genomic DNA afterXbaI digestion.Themajority (87%) of
AIDS isolates were from disseminated infection, while the majority (61%) of HIV-negative isolates were
from childrenwith cervical lymphadenitis.
Results Pulsed-¢eld gel electrophoresis classi¢ed strains whose electrophoretic patterns were at least 85%
similar into three clusters, A (four isolates), B (12 isolates), and C (15), while10 isolates remained outside of
these clusters.Therewas no statistically signi¢cant correlation of any PFGE cluster with a speci¢c patient
group.Within each patient group, no signi¢cant correlation of PFGE typewith time, place of residence or,
in the case of AIDS patients, hospital attendedwas observed.
Conclusions Genotypic similarities between isolates responsible for disseminated infection in AIDS
patients and lymphadenitis in HIV-negative children suggest that related strains, possibly from an
environmental source, cause both types of infections.
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I N T R O D U C T I O N
Mycobacterium avium complex (MAC) consists of the two spe-
ciesM. avium andM. intracellulare,with each species being sub-
divided further into distinct serovar groups [1]. MAC is the
most common non-tuberculous non-lepromatous mycobac-
terial complex of species associated with human disease [2],
while M. intracellulare strains are most often isolated from
healthy subjects, environmental sources, and pulmonary dis-
ease [2^4]. M. avium strains are most commonly isolated in
disseminated infection in AIDS patients and various infections
in HIV-negative patients [3^5]. Indeed,M. avium is recognized
as one of the most common opportunistic pathogens in
patients with late-stage HIV infection, when CD4 lympho-
cyte counts are less than 50/mm3 [3,5]. In HIV-negative adults,
M. avium predominantly causes pulmonary disease [2,3],
while in children less than 12 years old it is often responsible
for subacute lymphadenitis [6] and, less often, disseminated
disease [2]. However, other unusual infections, such as those
of the hand joints and bones, have been sporadically reported
[3].
Common serovars with di¡ering geographic frequencies
are often observed among M. avium isolates from AIDS and
HIV-negative patients [7^11]. However, the major drawback
of serotyping is that it requires large amounts of these slow-
growing organisms. In addition, the number of untypable
strains and of mixed serovars is high [2,3,8,9].
In contrast, chromosomal DNA ¢ngerprinting methods
for epidemiologic typing, whether by pulsed-¢eld gel electro-
phoresis (PFGE), RFLP and PCR with probes or primers
derived from mycobacterial insertion sequences, such as
ORIGINAL ARTICLE
Corresponding author and reprint requests: P.T.Tassios, Department of Micro-
biology, University of Athens, M. Asias 75,115 27 Athens, Greece
Tel: 3017489025/778 5638
Fax: 3017709180
E-mail: ptasios@cc.uoa.gr
= 2000 Copyright by the European Society of Clinical Microbiology and Infectious Diseases
IS1245 [12^17], have proved very useful and discriminatory,
compared to serotyping, plasmid pro¢ling, or multilocus
enzyme electrophoresis [8,18^20].
It is usually argued that MAC strains infecting humans are
of environmental origin. Nevertheless, it seems that geneti-
cally distinct strains are isolated from the stools of healthy car-
riers [21] or from pulmonary infections [22], compared to
those from the blood of HIV-positive patients. On the other
hand, related strains have been reported from the blood of
AIDS patients and the lymph nodes of children [23]. More
recent studies are also divided in their ¢ndings. Using IS1245
typing, identical M. avium strains were found to infect both
immunocompromised and immunocompetent patients, and
to be geographically widespread in Denmark [24], while a
predominantly AIDS-associated IS1245 RFLP pattern was
recognized among Italian strains from distinct geographic
areas [25]. On the other hand, using the same typing method,
diverseM. avium isolates from HIV-seropositive and -negative
children have also been reported [26].
In the present study, we used PFGE to assess the genetic
diversity ofM. avium isolates within and between two di¡er-
ent groups of patients, namely AIDS and HIV-negative
patients, the latter being mainly children with cervical lym-
phadenopathy.
M A TE R IA L S A N D M ET H O D S
Bacterial isolates
In total, 41 non-replicate clinical M. avium isolates were
obtained from the National Reference Center for Mycobac-
teria, at the Microbiology Laboratory of `Sotiria' Hospital for
Chest Disease. The isolates originated from specimens sent
from numerous Greek general hospitals over the period 1993^
97. Identi¢cation as MAC, by standard biochemical tests and a
DNA^rRNA hybridization test (SNAP; Syngene, San
Diego, USA), and characterization to the species level as M.
avium by PCR using primers AV6 and AV7, has already been
described for most of these isolates [27]. Randomly selected
strains from active infections of AIDS patients were isolated
from the following sources: 20 from blood cultures, two from
sputum, and one from skin (Table1). All patients had CD4
counts below 50/mm3, and symptoms of pyrexia 10^15 days
prior to hospital admission. Isolates from active infections of
HIV-negative patients were from the following sources: 11
from lymph node biopsies of children with cervical lympha-
denopathy, three from sputum, one from bronchoalveolar
lavage, one from a blood culture of adult patients with lung
infection, one from gastric lavage of a child with Evans' syn-
Table 1 Epidemiological information of AIDS patients and corresponding M. avium strains
No.
Date of
isolation Source Other disease
Age (years) at time
of isolation Sex
Residence at time
of isolation
Hospital(s)
attended
PFGE
cluster
497 97.06a Sputum None 39 M New Delhi, India 1 C
524 93.08 Blood Lymphoma 38 M Piraeus 1 A
535 93.02 Blood Cryptococcal meningitis 65 M Chios 2 B
543 93.03 Blood Lung tumor 32 M Athens 3 C
554 94.06 Blood PCPb/CMVc 28 F Athens 2 B
574 97.10 Blood Herpes zoster 33 M Athens 6, 2 B
578 94.02 Blood Tuberculosis 45 M Athens 2
579 95.05 Blood PCP 38 M Crete 7 B
580 94.08 Blood PCP/KSd 33 M Athens 2 C
581 94.09 Blood KS 37 M Skiathos 3 B
606 95.04 Blood Tuberculosis 61 M Athens 2
607 95.06 Sputum None 53 M Athens 2
621 95.03 Blood a-Hemophilia/PCP 62 M Piraeus 3 C
636 94.10 Blood a-Hemophilia/lymphoma 17 M Athens 3 B
637 95.04 blood CMV 28 M Salamina 4
638 95.12 Blood Lymphoma 34 M Piraeus 3, 2 B
643 95.02 Blood KS/lymphoma 45 F Athens 8 C
689 95.03 Blood KS/CMV 48 M Athens 2
694 95.05 Blood a-Hemophilia 45 M Athens 3 B
769 95.03 Blood KS 37 M Athens 2
774 96 (NKe) Blood NK NK M NK 3 C
822 96 (NK) Blood NK NK M NK 5 C
825 97.06 Skin Tuberculosis 49 F Athens 1 C
aYear.month; bPneumocystis carinii pneumonia; ccytomegalovirus infection; dKaposi's sarcoma; enot known.
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drome and symptoms of intra-abdominal infection, and one
from pus of an adult with hip joint infection (Table 2). All iso-
lates were subcultured from Lowenstein^Jensen agar onto
Soutons agar, and stored atÿ20 C for future analysis.
Pulsed-®eld gel electrophoresis
Isolates were transferred from frozen stocks to 10mL of 7H9
Middlebrook (BBL; Cockeysville, MD, USA) broth contain-
ing 10% ADC (albumin fraction V, dextrose and catalase;
BBL), and the culturewas incubated at 37 C for 4^7 days with
agitation, until an optical density of 0.2 at 600 nm was
obtained. The resulting growth was checked for contamina-
tion by blood agar culture, and a Ziehl^Neelsen smear was
checked for acid fastness. A cell pellet was obtained by centri-
fugation at 1500 g for 20min at 4 C. The pellet was resus-
pended in 1mL of TE (10mM Tris, 1mM EDTA, pH 8), and
centrifuged at 5000 g for 5min at 4 C. The pellet was then
resuspended in 200 mL of TE, transferred into a vial contain-
ing three or four glass beads and shaken vigorously for 50 s.
The cell suspension was then transferred into another vial and
freeze^thawed twice using liquid nitrogen and a 37 Cwater-
bath, to break the mycobacterial cell wall. In total, 100 mL of
the cell suspensionwas mixedwith100 mL of 2% low-melting
agarose (Sigma, St Louis, MO, USA) inTE, and the mixture
was poured into 100-mL plug molds (BioRad, Milano, Italy).
The plugs were incubated in 500 mL of TE containing 1mg of
lysozyme (Sigma) for 2 h at 37 C, washed brie£y with TE,
and incubated in 500 mL of 1% sodium dodecylsulfate (SDS)
in TE containing 1mg of proteinase K (Sigma) overnight at
56 C. After washing once with TE, proteinase Kwas inacti-
vated by incubating the plug in 1mL of TE containing 50 mM
phenyl methyl sulfonyl £uoride for 30min at room tempera-
ture. Plugs were then washed six times for 30min withTE at
room temperature.They could then be stored at 4 C for up to
4weeks. One half of each plug was digested with 20UofXbaI
(New England Biolabs, Beverly, MA, USA) overnight at 37
C, and then loaded onto a 1% agarose gel prepared and run in
0.5 Tris-boric acid-EDTA bu¡er (45mM Tris, 1.0M EDTA,
45mM boric acid) in a CHEF DRIII apparatus (BioRad).
Conditions were 11 C and 6V/cm for 5 h with a constant
switch time of 9 s, followed by 15 h with switch times linearly
ramped from 20 to 40 s. Molecular weight markers were bac-
teriophage lambda DNA concatamers (New England Bio-
labs). Gels were stained with ethidium bromide and
documented underUVillumination (Herolab,Wiesloch, Ger-
many). The digital images of the gels were processed by the
GelCompar software (AppliedMaths, Kortrijk, Belgium), and
patterns of DNAbands greater than 48.5 kb in size were com-
pared by band correlation using the Dice coe¤cient and
UPGMA algorithm, with a 2% tolerance in band position dif-
ference.
Statistical tests
Chi-square tests or the Fisher exact test of signi¢cance were
used to calculate two-tailed probabilities.
Table 2 Epidemiologic information on HIV-negative patients and corresponding M. avium strains
No.
Date of
of isolation Source Disease
Age (years) at time
of isolation Sex
Residence at time
of isolation
PFGE
cluster
506 93.01a Sputum Pneumonia 62 M Athens C
536 94.03 Sputum Tuberculosis 65 M Piraeus
548 93.02 Lymph node biopsy Cervical lymphadenopathy 5 M Athens C
556 94.02 Lymph node biopsy Cervical lymphadenopathy 2 M Korinthos A
558 94.08 Lymph node biopsy Cervical lymphadenopathy 8 M Athens C
559 94.06 Pus Joint infection NKb F Amphissa A
573 94.03 Lymph node biopsy Cervical lymphadenopathy 5 F Gytheio C
582 94.07 Blood Pneumonia 45 F Athens A
583 94.01 Sputum Pneumonia (NK) F NK C
597 93.07 Lymph node biopsy Cervical lymphadenopathy 3 M Crete B
619 95.06 Gastric lavage Evans' syndrome 5 F Athens
627 94.12 Lymph node biopsy Cervical lymphadenopathy 2 M Athens B
629 95.08 BALc Pneumonia 60 F Athens
640 95.03 Lymph node biopsy Cervical lymphadenopathy 2 M Athens C
686 95.02 Lymph node biopsy Cervical lymphadenopathy 3 F Kefallonia C
696 94.08 Lymph node biopsy Cervical lymphadenopathy 3 F Athens B
782 95.08 Lymph node biopsy Cervical lymphadenopathy 12 M Ioannina B
2223 94.07 Lymph node biopsy Cervical lymphadenopathy 6 M Athens
aYear.month; bnot known; cbronchoalveolar lavage.
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R E S U L TS
In order to determine whether speci¢c genotypes of M.
avium were associated with AIDS patients or HIV-negative
patients, 23 isolates from the former (Table1) and 18 from the
latter group (Table 2) were typed by PFGE.The AIDS group
contained mostly (87%) isolates responsible for disseminated
infection, while the majority (61%) of isolates from HIV-
negative patients were implicated in cervical lymphadenopa-
thy in children.
PFGE of genomic DNA after XbaI digestion typed all
strains, providing an adequate spectrum of fragments for
strain discrimination (Figure 1).When electrophoretic pro¢les
were compared using the GelCompar software, three clusters,
A^C, of more than two isolates whose PFGE patterns were
similar by 85% or more could be observed (Figure 2). Accept-
ability of these clusters was assessed by visual inspection. It
was thereby con¢rmed that PFGE patterns of isolates within
each cluster di¡ered by a maximum of six bands, suggested to
correspond to two mutations and deemed to represent a sig-
ni¢cant level of genetic relatedness [28,29]. Cluster C con-
tained the largest number of isolates (15), with clusters A and B
being represented by four and12 isolates, respectively.Though
the distribution of isolates from AIDS or HIV-negative
patients di¡ered among the three clusters (respectivelyone and
three in A, eight and four in B, and eight and seven in C), these
di¡erences were not signi¢cant (P 0.34). Ten isolates, six
from AIDS patients (including two identical strains) and four
from HIV-negative patients, remained outside of these clus-
ters.
There was no evidence of time clustering, or association
between PFGE pattern and area of residence, in either patient
group. In the case of AIDS patients, four of the eight type B
isolates could be associatedwith attendance at each of hospitals
2 and 3, while three of eight type C isolates could be associated
with attendance at hospital 3. However, it was impossible to
Figure 1 PFGE of isolates from AIDS and HIV-negative
patients. PFGE patterns of isolates belonging to the three indi-
cated clusters are included. Isolate numbers are above the gel.
The sizes of DNA markers in Kb are shown to the left of the
gel. All lanes are from the same gel.
Figure 2 Dendrogram of PFGE patterns of all isolates from
AIDS () and HIV-negative (±) patients. Clusters A±C are indi-
cated; the similarity of patterns within each cluster is shown in
parentheses. A scale of pattern similarity is displayed at the
top.
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assess retrospectively whether nosocomial transmission had
occurred.
D IS C U S S IO N
Analysis of M. avium isolates from AIDS and HIV-negative
patients by PFGE demonstrated that many strains causing dis-
seminated infection in the former group and lymphadenitis in
the latter were genetically related, belonging to one of three
distinct clusters.
These results are consistent with those of several previous
studies concerned with typing of MAC isolates from AIDS
and HIV-negative patients. Common serotypes, though pre-
sent with di¡erent frequencies, have been documented in the
two patient groups [7^9,11]. Clusters of genotypically similar
isolates from both types of patients have also been observed by
IS1311 and IS1245 RFLP [16,24], as well as by sequencing of
the ribosomal RNA internal transcribed sequences [22].
Though a diversity of PFGE or IS1245 RFLP types among
AIDS isolates has been reported [12,26,30], other studies have
also demonstrated similarities in PFGE patterns among iso-
lates from patients with and without AIDS [31], and from dis-
seminated infection in AIDS patients [32], especially within
the same city [33], as was largely the case in the present study.
No signi¢cant association of PFGE pattern with time of
isolation, location of residence or, in the case of AIDS patients,
hospital attended could be observed in either patient group.
The isolation of genetically similar strains from both AIDS
andHIV-negative patients may point to an environmental ori-
gin, such as water [34], for M. avium in both groups. If this
were true in the present study, the environmental clones
responsible would have to be widely distributed in di¡erent
parts of Greece. In the case of AIDS patients, person-to-per-
son transmission under conditions of close and prolonged
proximity, such as during hospitalization, cannot be ruled out
either.
Alternatively, it may be that genetically similar strains
cause two di¡erent kinds of invasive infection in individuals
whose immune system is compromised or not fully mature:
disseminated infection in AIDS patients and cervical lympha-
denitis in young HIV-negative children, respectively. This
hypothesis would be compatible with other studies, which
have shown that genotypically similar MAC strains are iso-
lated from AIDS patients and children with lymphadenitis
[22].
A comparison of clinical strains with environmental isolates
should help to clarify this issue.
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